Who is the ceo of siga technologies? NEW YORK, Sept. 07, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company, today announced that Dr. Phil Gomez, the Company’s Chief Executive Officer, will be a speaker at the NCT USA conference on September 8, in Baltimore, Maryland. Dr.What does siga technologies do for a living? The company markets pharmaceutical solutions for anti-viral smallpox treatment. The company trades publicly as SIGA on NASDAQ . In September 2009, SIGA Technologies received a $1.6 million research fund from the National Institutes of Health ("NIH") for its broad-spectrum antiviral candidates.What does siga stand for? NEW YORK, June 30, 2021 (GLOBE NEWSWIRE) -- SIGA Technologies, Inc. (SIGA) (NASDAQ: SIGA), a commercial-stage pharmaceutical company focused on the health security market, today announced that it provided TPOXX® (tecovirimat) to Liverpool University Hospitals NHS Foundation Trust, in the United Kingdom (UK).Why is siga technologies stock trading higher than a year ago? With partnerships covering several government entities, the firm’s leading product protects against smallpox bioterror attacks. SIGA Technologies (NASDAQ: SIGA) SIGA is trading higher than it did a year ago, ebbing and flowing much like any normal stock.
This is the second appeal by SIGA Technologies, Inc. ("SIGA") from a Court of Chancery judgment awarding PharmAthene, Inc. ("PharmAthene") damages stemming from failed merger and license negotiations between the parties. In the first appeal, this Court upheld the Court of Chancery's finding that SIGA in bad faith breached its contractual